Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)
Sponsor: Assaf-Harofeh Medical Center
Summary
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency. HBOT mechanisms of tissue oxygenation and anti-inflammatory effect may explain these findings. The purpose of the current study is the evaluate the efficacy of HBOT in moderate-severe COVID-19 patients in a randomized controlled manner.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2020-04-30
Completion Date
2020-11-01
Last Updated
2026-04-21
Healthy Volunteers
No
Conditions
Interventions
Hyperbaric oxygen therapy
8 sessions in 4 days of breathing 100% oxygen in 2.2 ATA. Each session is 60 minutes. 1 meter/minute compression/decompression
Locations (1)
Amir Hadanny
Ẕerifin, Israel